Therapeutic drug monitoring in cancer chemotherapy

DM Bach, JA Straseski, W Clarke - Bioanalysis, 2010 - Taylor & Francis
For a select number of drugs, proper management of patients includes monitoring serum or
plasma concentrations of the drugs and adjusting the doses accordingly–this practice is …

[HTML][HTML] The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes

A Makarov, J Began, IC Mautone, E Pinto… - Microbial Cell, 2023 - ncbi.nlm.nih.gov
The surface proteins of parasitic protozoa mediate functions essential to survival within a
host, including nutrient accumulation, environmental sensing and immune evasion. Several …

Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes

MB Lustberg, S Pant, AS Ruppert, T Shen… - Cancer chemotherapy …, 2012 - Springer
Purpose Suramin, a polysulfonated naphthylurea, inhibits the actions of polypeptide growth
factors including acidic and basic fibroblast growth factors (aFGF and bFGF), which confer …

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

ET Lam, JLS Au, GA Otterson… - Cancer chemotherapy …, 2010 - Springer
Purpose In preclinical models, non-cytotoxic suramin (concentrations< 50 μM) potentiates
the activity of multiple chemotherapeutic agents. The present study evaluated the safety and …

[HTML][HTML] Value of plasma vitamin D level and nomogram model for predicting the prognosis of patients with small cell lung cancer treated with platinum plus etoposide …

X Zhang, W Li, Y Liu, L Xu, X Wang… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Background: To assess the value of plasma vitamin D level and nomogram model in
predicting the prognosis of patients with small cell lung cancer (SCLC) treated with platinum …

Corneal neovascularization: a combined approach of bevacizumab and suramin showed increased antiangiogenic effect through downregulation of BFGF and P2X2

ES Lopez, GA Ortiz, C Potilinski, JO Croxatto… - Current Eye …, 2018 - Taylor & Francis
Purpose: The objective is to analyze the antiangiogenic mechanism of suramab, a
pharmaceutical compound of bevacizumab and suramin, in a rabbit model of corneal …

Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma

S George, R Dreicer, JJL Au, T Shen, BI Rini… - Clinical genitourinary …, 2008 - Elsevier
Background Renal cell carcinoma (RCC) is recognized as a neoplasm resistant to
chemotherapy. In vitro experiments demonstrated that suramin, at noncytotoxic doses …

Translational Research: Using Suramin as a Platform

T Shen - 2010 - rave.ohiolink.edu
Laboratory scientists in cancer research typically focus on unraveling the molecular basis of
carcinogenesis, identifying novel cellular and molecular targets for interventions, and …

Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy

JLS Au, MG Wientjes - US Patent 8,580,857, 2013 - Google Patents
(57) ABSTRACT A method for determining a therapeutically effective amount of Suramin for
administering to a patient, who is to receive a cytotoxic agent, which comprises the steps of …

Translational Research in Cancer: Preclinical Pharmacodynamics and Cancer Epidemiology

J Ji - 2009 - rave.ohiolink.edu
Translational research bridges preclinical and clinical research and shortens distance
between these two areas in biomedical research. In preclinical study, our laboratory has …